AC
ANGO icon

Aristides Capital’s AngioDynamics ANGO Stock Holding History

Aristides Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,183
Closed -$244K – 268
2023
Q4 		$244K Buy
+31,183
New +$216K 0.09% 176
2023
Q1 		– Sell
-18,489
Closed -$255K – 177
2022
Q4 		$255K Buy
+18,489
New +$257K 0.13% 124

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Aristides Capital's ANGO Position: Q1 2024 in Review

Aristides Capital sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 31,183 shares — an estimated $244K sold.

Aristides Capital first reported a position in ANGO in Q4 2022 and held it in 2 quarters. The position peaked at $255K in Q4 2022. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

  • Aristides Capital reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
  • Aristides Capital sold 31,183 AngioDynamics shares in Q1 2024, an estimated $244K.
  • Aristides Capital first reported a position in AngioDynamics in Q4 2022 and held it in 2 quarters.
  • Aristides Capital's AngioDynamics position peaked at $255K in Q4 2022.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on Aristides Capital's 13F filing for Q1 2024, filed 15 May 2024.